Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.8%

1 terminated/withdrawn out of 26 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

23%

6 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
7(36.8%)
Phase 2
6(31.6%)
Phase 4
3(15.8%)
Phase 3
3(15.8%)
19Total
N/A(7)
Phase 2(6)
Phase 4(3)
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT02771405Phase 3Completed

Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

Role: lead

NCT07358741Recruiting

Standard Two-Day Advanced Life Support (ALS) Versus One Day Recertification Course

Role: lead

NCT07318766Not ApplicableCompleted

Incentive Spirometer in Liver Transplant Recipients

Role: collaborator

NCT07085832Not ApplicableRecruiting

Assessment of Cardiopumonary Resuscitation (CPR) Competency Post ALS Course

Role: lead

NCT06063993Completed

Evaluation of Perfusion Index Change Post Passive Leg Raising for Fluid Responsiveness in Critically Ill

Role: lead

NCT06075875Not ApplicableUnknown

Vegetable Proteins Versus Mixed Animal Proteins on the Outcome of Hepatic Encephalopathy

Role: lead

NCT06067464Unknown

Evaluation of Perfusion Index as a Prognostication Tool for High Quality Cardiopulmonary Resuscitation

Role: lead

NCT06062719Phase 2Unknown

Role of Octreotide in Non Variceal Bleeding

Role: lead

NCT05324618Phase 4Completed

Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

Role: collaborator

NCT05115123Phase 2Completed

Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy

Role: collaborator

NCT05343780Phase 2Completed

Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH

Role: collaborator

NCT03455296Not ApplicableCompleted

Fluid Management Surgical Patients in Intensive Care Unit.

Role: lead

NCT03389360Completed

Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant

Role: lead

NCT03455322Phase 4Completed

Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.

Role: lead

NCT03448848Not ApplicableCompleted

Role of Branched-chain Amino Acids Infusion as Adjunct Therapy Post Liver Surgery for Patients in Intensive Care Unit

Role: lead

NCT03461523Completed

Observational, Prospective, Single-center Study: Should Body Mass Index (BMI) be Added to the Scoring Criteria of Hepatic Critically Ill Patients in Intensive Care Unit??

Role: lead

NCT04750135Phase 2Unknown

Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis

Role: lead

NCT04736836Phase 4Completed

Microbial Resistance of Rifaximin in Hepatic Encephalopathy

Role: lead

NCT04459403Completed

Psychiatric Disturbances and COVID-19 Infection

Role: collaborator

NCT04468685Phase 2Completed

Ondansetron Effect on Pain Relief After Laparoscopic Cholecystectomy

Role: lead